New report outlines potential positive and negative consequences for the field
WASHINGTON (April 23, 2015)
In a white paper released today by the Personalized Medicine Coalition (PMC), the nonprofit education and advocacy organization encourages health care policymakers to consider how alternative payment models (APMs) may promote or impede access to personalized medicine tests and treatments that have the potential to improve patient outcomes while lowering systemic costs.
Following the U.S. Department of Health and Human Services’ recent announcement of a plan to tie 50 percent of fee-for-service Medicare payments to quality or value in three years by linking them to APMs, PMC Executive Vice President Amy M. Miller, Ph.D., said thinking about these issues now is imperative.
“We must consider the downstream implications of these policies,” Miller said. “These reforms will impact patient access and influence the pace of innovation. It is therefore imperative that they support personalized medicine.”
The report, developed by PMC in partnership with ML Strategies, a government relations consulting firm, explores the potential positive and negative consequences that APMs might have on personalized medicine, with a particular focus on how Accountable Care Organizations (ACOs), bundled payments, medical homes and clinical pathways might impact the field.
As stated in the conclusion of the paper, PMC believes that “through open dialogue and transparent processes that include all stakeholders, a more efficient and high-quality health system is within reach.”
About the Personalized Medicine Coalition:
The Personalized Medicine Coalition (PMC), representing innovators, scientists, patients, providers and payers, promotes the understanding and adoption of personalized medicine concepts, services and products to benefit patients and the health system. For more information about PMC, visit www.personalizedmedicinecoalition.org.
For more information about ML Strategies, please visit www.mlstrategies.com.